# Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

> **NCT06078319** · — · COMPLETED · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 189 (actual)

## Conditions studied

- Adherence, Patient
- Adherence, Treatment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06078319
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-18
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06078319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06078319, "Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06078319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*